Recombinant Lecanemab Biosimilar antibody
The Human Monoclonal anti-Lecanemab Biosimilar antibody (ABIN7795162) specifically detects Lecanemab Biosimilar in FACS and in vivo.
The antibody is reactive with Human samples.
Catalog No. ABIN7795162
$278.85
Plus shipping costs $50.00
1 mg
Shipping to:
United States
Delivery in 21 to 27 Business Days
Quick Overview for Recombinant Lecanemab Biosimilar antibody (ABIN7795162)
Target
Lecanemab Biosimilar
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
Un-conjugated
Application
Flow Cytometry (FACS), In vivo Studies (in vivo)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody
-
Characteristics
- The anti-human amyloid-beta monoclonal antibody lecanemab biosimilar was produced in mammalian cells.
-
Purification
- Protein A or G affinity column
-
Purity
- >95 % by reducing SDS-PAGE
-
Endotoxin Level
- < 1 EU per 1 mg of the protein by the LAL method
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- > 3 mg/mL
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- Lecanemab Biosimilar
-
Target Type
- Biosimilar
Target
-
You are here:
